Chief Business Officer Helen Katrina Tayton-Martin sold $1.7M of Adaptimmune Therapeutics Plc

Sold$1,748,180

$8.74Price

200,000Shares

−100%Stake

What ADAP did after the filing

Prices for ADAP after this filing aren't in yet.

Traded Mon, Aug 3. Filed Tue, Aug 4, 5:02 PM ET, after the close. Not investment advice.